Representative Greg Landsman (D-Ohio) recently sold shares of Cencora, Inc. (NYSE:COR). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $15,001 and $50,000 in Cencora stock on March 27th. The trade occurred in the Representative’s “SARAH LANDSMAN TRADITIONAL IRA” account.
Representative Greg Landsman also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of CrowdStrike (NASDAQ:CRWD) on 3/27/2025.
- Sold $1,001 – $15,000 in shares of Cadence Design Systems (NASDAQ:CDNS) on 3/27/2025.
- Sold $15,001 – $50,000 in shares of Simon Property Group (NYSE:SPG) on 3/27/2025.
- Sold $1,001 – $15,000 in shares of L3Harris Technologies (NYSE:LHX) on 3/27/2025.
- Sold $15,001 – $50,000 in shares of Visa (NYSE:V) on 3/27/2025.
- Sold $15,001 – $50,000 in shares of Alphabet (NASDAQ:GOOGL) on 3/27/2025.
- Sold $1,001 – $15,000 in shares of Ameriprise Financial (NYSE:AMP) on 3/27/2025.
- Sold $15,001 – $50,000 in shares of Salesforce (NYSE:CRM) on 3/27/2025.
- Sold $1,001 – $15,000 in shares of Equinix (NASDAQ:EQIX) on 3/27/2025.
- Sold $15,001 – $50,000 in shares of Procter & Gamble (NYSE:PG) on 3/27/2025.
Cencora Price Performance
Shares of NYSE:COR traded up $4.12 during trading hours on Thursday, hitting $278.01. 380,109 shares of the company’s stock traded hands, compared to its average volume of 1,493,311. The company has a debt-to-equity ratio of 16.40, a quick ratio of 0.54 and a current ratio of 0.92. The company has a market cap of $53.91 billion, a price-to-earnings ratio of 39.55, a price-to-earnings-growth ratio of 1.31 and a beta of 0.55. Cencora, Inc. has a 52 week low of $214.77 and a 52 week high of $296.65. The company’s fifty day simple moving average is $259.12 and its two-hundred day simple moving average is $244.21.
Cencora Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were issued a $0.55 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.79%. Cencora’s dividend payout ratio (DPR) is presently 31.29%.
Analyst Ratings Changes
COR has been the topic of a number of recent research reports. Wells Fargo & Company boosted their target price on Cencora from $251.00 to $274.00 and gave the company an “equal weight” rating in a research note on Friday, March 14th. StockNews.com upgraded Cencora from a “hold” rating to a “buy” rating in a report on Wednesday, March 12th. Evercore ISI upped their price objective on shares of Cencora from $270.00 to $280.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Finally, JPMorgan Chase & Co. raised their target price on Cencora from $289.00 to $301.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $280.20.
Get Our Latest Stock Report on Cencora
Insider Activity at Cencora
In other news, CEO Robert P. Mauch sold 4,970 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $255.00, for a total transaction of $1,267,350.00. Following the sale, the chief executive officer now directly owns 51,070 shares of the company’s stock, valued at $13,022,850. This represents a 8.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Silvana Battaglia sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $242.24, for a total transaction of $1,211,200.00. Following the completion of the sale, the executive vice president now directly owns 15,374 shares of the company’s stock, valued at approximately $3,724,197.76. This represents a 24.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,675 shares of company stock worth $8,034,778 over the last three months. Company insiders own 10.80% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. JFS Wealth Advisors LLC raised its stake in Cencora by 63.0% during the 4th quarter. JFS Wealth Advisors LLC now owns 119 shares of the company’s stock valued at $27,000 after purchasing an additional 46 shares during the last quarter. Banque Transatlantique SA bought a new position in shares of Cencora during the 4th quarter worth about $29,000. SBI Securities Co. Ltd. acquired a new position in shares of Cencora during the fourth quarter valued at about $30,000. Kentucky Trust Co bought a new stake in shares of Cencora in the fourth quarter valued at about $33,000. Finally, Householder Group Estate & Retirement Specialist LLC grew its position in Cencora by 85.2% during the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 150 shares of the company’s stock worth $33,000 after buying an additional 69 shares in the last quarter. 97.52% of the stock is owned by institutional investors.
About Representative Landsman
Greg Landsman (Democratic Party) is a member of the U.S. House, representing Ohio’s 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Landsman (Democratic Party) is running for re-election to the U.S. House to represent Ohio’s 1st Congressional District. He declared candidacy for the 2026 election.
Greg Landsman was born in Cincinnati, Ohio, and lives in Mt. Washington, Ohio. Landsman earned a B.A. in economics and political science from Ohio University and an M.A. in theological studies, religion, and public policy from Harvard University in 2004. His career experience includes working as the executive director of The Strive Partnership with the KnowledgeWorks Foundation and the director of the Ohio Governor’s Office of Faith-Based and Community Initiatives.
Cencora Company Profile
Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Read More
- Five stocks we like better than Cencora
- Growth Stocks: What They Are, What They Are Not
- Joby Aviation: Operational Momentum vs. Market Sentiment
- Where to Find Earnings Call Transcripts
- Broadcom’s Big Outperformance Shows Strength Amid Tariff Decline
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Carvana: Can Turnaround Strength Outdrive Market Headwinds?
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.